The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
Data up to Jan 2025
Total Citations Per Year
Abstract
References (165)
A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.
1995 • 5,050 citations
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
1976 • 3,228 citations
Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
2000 • 2,358 citations
Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System
2005 • 1,348 citations
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
1999 • 911 citations
Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor
2002 • 888 citations
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin
2001 • 843 citations
Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification
2003 • 839 citations
Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System
2001 • 786 citations
Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor
2001 • 753 citations
Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver
2001 • 722 citations
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
2002 • 682 citations
Nuclear Pregnane X Receptor and Constitutive Androstane Receptor Regulate Overlapping but Distinct Sets of Genes Involved in Xenobiotic Detoxification
2002 • 642 citations
Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines
2007 • 574 citations
A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and Japan
2006 • 565 citations
Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics
2003 • 514 citations
Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics
2007 • 461 citations
The Multidrug Resistance Protein 5 Functions as an ATP-dependent Export Pump for Cyclic Nucleotides
2000 • 438 citations
Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin
2007 • 414 citations
Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption
2007 • 409 citations
Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs.
2002 • 406 citations
Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family
2008 • 406 citations
Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans
2007 • 400 citations
Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters
2006 • 395 citations
P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs
2000 • 382 citations
Why is it Challenging to Predict Intestinal Drug Absorption and Oral Bioavailability in Human Using Rat Model
2006 • 371 citations
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver
2002 • 369 citations
Nuclear Receptors and the Regulation of Drug‐Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs
2007 • 362 citations
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
2005 • 358 citations
Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2)
2005 • 351 citations
Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
2008 • 345 citations
Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
2008 • 343 citations
Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*
1995 • 342 citations
Human Organic Anion Transporting Polypeptide-C (SLC21A6) Is a Major Determinant of Rifampin-Mediated Pregnane X Receptor Activation
2003 • 325 citations
Effect of OATP1B Transporter Inhibition on the Pharmacokinetics of Atorvastatin in Healthy Volunteers
2006 • 315 citations
Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations.
1999 • 308 citations
Several major antiepileptic drugs are substrates for human P-glycoprotein
2008 • 296 citations
Evidence for inverse effects of OATP-C (SLC21A6) *5 and *1b haplotypes on pravastatin kinetics
2004 • 293 citations
Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery
1999 • 292 citations
Unmasking the Dynamic Interplay between Intestinal P-Glycoprotein and CYP3A4
2002 • 286 citations
Naringin is a Major and Selective Clinical Inhibitor of Organic Anion-Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice
2007 • 281 citations
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: A new type of drug/drug interaction
2000 • 281 citations
Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3
2002 • 279 citations
Intestinal permeability and its relevance for absorption and elimination
2007 • 270 citations
Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P‐glycoprotein
2002 • 268 citations
Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor.
2001 • 255 citations
Pharmacokinetic Interactions of Drugs with St John’s Wort
2004 • 254 citations
Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories
2008 • 253 citations
Prediction of Human Pharmacokinetics Using Physiologically Based Modeling: A Retrospective Analysis of 26 Clinically Tested Drugs
2007 • 248 citations
Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males
2006 • 247 citations
MDR3 P-glycoprotein, a Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs and Directly Interacts with Drugs as Judged by Interference with Nucleotide Trapping
2000 • 246 citations
Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype*1
2004 • 241 citations
Metformin Transport by a Newly Cloned Proton-Stimulated Organic Cation Transporter (Plasma Membrane Monoamine Transporter) Expressed in Human Intestine
2007 • 234 citations
Variability in Caco-2 and MDCK Cell-Based Intestinal Permeability Assays
2007 • 231 citations
Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice
2004 • 229 citations
Antimalarial Artemisinin Drugs Induce Cytochrome P450 and MDR1 Expression by Activation of Xenosensors Pregnane X Receptor and Constitutive Androstane Receptor
2005 • 220 citations
Oatp2 Mediates Bidirectional Organic Solute Transport: A Role for Intracellular Glutathione
2000 • 219 citations
Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception
2005 • 213 citations
Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart
2006 • 209 citations
Interaction of Organic Cations with a Newly Identified Plasma Membrane Monoamine Transporter
2005 • 187 citations
Identification of Thyroid Hormone Transporters in Humans: Different Molecules Are Involved in a Tissue-Specific Manner*,†
2001 • 183 citations
Organic Anion Transporting Polypeptide Mediates Organic Anion/HCO3− Exchange
1997 • 179 citations
Bile Salt Export Pump (BSEP/ABCB11) Can Transport a Nonbile Acid Substrate, Pravastatin
2005 • 174 citations
Peroxisome Proliferator-activated Receptor γ-regulated ABCG2 Expression Confers Cytoprotection to Human Dendritic Cells
2006 • 171 citations
Irinotecan-induced Diarrhea: Functional Significance of the Polymorphic ABCC2 Transporter Protein
2006 • 170 citations
Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor
2002 • 167 citations
ATP-binding cassette, subfamily G (ABCG family)
2006 • 165 citations
Impact of Genetic Polymorphisms of Transporters on the Pharmacokinetic, Pharmacodynamic and Toxicological Properties of Anionic Drugs
2008 • 162 citations
SLCO1B1 (OATP1B1, an Uptake Transporter) and ABCG2 (BCRP, an Efflux Transporter) Variant Alleles and Pharmacokinetics of Pitavastatin in Healthy Volunteers
2007 • 158 citations
In Vivo Modulation of Intestinal CYP3A Metabolism by P-Glycoprotein: Studies Using the Rat Single-Pass Intestinal Perfusion Model
2003 • 157 citations
Segmental Dependent Transport of Low Permeability Compounds along the Small Intestine Due to P-Glycoprotein: The Role of Efflux Transport in the Oral Absorption of BCS Class III Drugs
2008 • 157 citations
Effect of ABCG2 genotype on the oral vioavailability of topotecan
2005 • 154 citations
Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
2008 • 153 citations
Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain
2006 • 153 citations
Differential Modulation of the Human Liver Conjugate Transporters MRP2 and MRP3 by Bile Acids and Organic Anions
2003 • 152 citations
Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients
2007 • 147 citations
Bile acid transporters in health and disease
2008 • 145 citations
Transport of antiviral 3′-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes
2001 • 144 citations
ABCB1 Pharmacogenetics: Progress, Pitfalls, and Promise
2007 • 141 citations
Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe
2008 • 137 citations
The Use of BDDCS in Classifying the Permeability of Marketed Drugs
2008 • 137 citations
Expression of the Steroid and Xenobiotic Receptor and Its Possible Target Gene, Organic Anion Transporting Polypeptide-A, in Human Breast Carcinoma
2006 • 134 citations
Effects of Drug Transporters on Volume of Distribution
2009 • 133 citations
Physiology, structure, and regulation of the cloned organic anion transporters
2008 • 131 citations
Differential Inhibition of Rat and Human Na+-Dependent Taurocholate Cotransporting Polypeptide (NTCP/SLC10A1)by Bosentan: A Mechanism for Species Differences in Hepatotoxicity
2007 • 129 citations
Induction of Intestinal P-glycoprotein by St John's Wort Reduces the Oral Bioavailability of Talinolol
2007 • 128 citations
Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment
2005 • 127 citations
The Human Na+-Taurocholate Cotransporting Polypeptide Gene Is Activated by Glucocorticoid Receptor and Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α, and Suppressed by Bile Acids via a Small Heterodimer Partner-Dependent Mechanism
2005 • 127 citations
MRP class of human ATP binding cassette (ABC) transporters: historical background and new research directions
2008 • 123 citations
Elucidating Rifampin's Inducing and Inhibiting Effects on Glyburide Pharmacokinetics and Blood Glucose in Healthy Volunteers: Unmasking the Differential Effects of Enzyme Induction and Transporter Inhibition for a Drug and Its Primary Metabolite
2008 • 122 citations
The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15
2008 • 121 citations
Breast Cancer Resistance Protein (Bcrp1/Abcg2) Limits Net Intestinal Uptake of Quercetin in Rats by Facilitating Apical Efflux of Glucuronides
2005 • 121 citations
Organic cation transporters
2008 • 121 citations
Applications of Physiologically Based Absorption Models in Drug Discovery and Development
2008 • 118 citations
Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport
2007 • 116 citations
Pharmacogenetics of OATP ( SLC21 / SLCO ), OAT and OCT ( SLC22 ) and PEPT ( SLC15 ) Transporters in the Intestine, Liver and Kidney
2008 • 112 citations
A variant 2677A allele of the gene affects fexofenadine disposition
2004 • 112 citations
Challenges and opportunities with modelling and simulation in drug discovery and drug development
2007 • 111 citations
Role of MRP4 and MRP5 in biology and chemotherapy
2002 • 111 citations
Human Organic Anion-Transporting Polypeptide OATP-A (SLC21A3) Acts in Concert with P-Glycoprotein and Multidrug Resistance Protein 2 in the Vectorial Transport of Saquinavir in Hep G2 Cells
2003 • 109 citations
Kinetic Analyses for Species Differences in P-glycoprotein-Mediated Drug Transport
2006 • 107 citations
Distribution of monocarboxylate transporters MCT1-MCT8 in rat tissues and human skeletal muscle
2006 • 106 citations
The Role of Placental Breast Cancer Resistance Protein in the Efflux of Glyburide across the Human Placenta
2008 • 103 citations
FUNCTIONAL EXPRESSION OF SINUSOIDAL DRUG TRANSPORTERS IN PRIMARY HUMAN AND RAT HEPATOCYTES
2005 • 103 citations
Substrate Overlap between Mrp4 and Abcg2/Bcrp Affects Purine Analogue Drug Cytotoxicity and Tissue Distribution
2007 • 100 citations
Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide
2006 • 99 citations
Monocarboxylate transporter 1 (MCT1) plays a direct role in short‐chain fatty acids absorption in caprine rumen
2006 • 98 citations
Absolute Difference of Hepatobiliary Transporter Multidrug Resistance-Associated Protein (MRP2/Mrp2) in Liver Tissues and Isolated Hepatocytes from Rat, Dog, Monkey, and Human
2008 • 96 citations
Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics
2006 • 96 citations
Drug Metabolizing Enzymes
2003 • 95 citations
The Operational Multiple Dosing Half-life: A Key to Defining Drug Accumulation in Patients and to Designing Extended Release Dosage Forms
2008 • 94 citations
Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.
1999 • 93 citations
Comparison of "type I" and "type II" organic cation transport by organic cation transporters and organic anion-transporting polypeptides.
2001 • 91 citations
Pharmacodynamics of Carbamazepine-mediated Induction of CYP3A4, CYP1A2, and Pgp as Assessed by Probe Substrates Midazolam, Caffeine, and Digoxin
2007 • 91 citations
Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patients
2006 • 90 citations
Biopharmaceutics Classification of Selected β-Blockers: Solubility and Permeability Class Membership
2007 • 90 citations
Localization of organic anion transporting polypeptides in the rat and human ciliary body epithelium
2004 • 88 citations
Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats
2004 • 88 citations
FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade
2004 • 85 citations
Functional and Genetic Diversity in the Concentrative Nucleoside Transporter, CNT1, in Human Populations
2004 • 84 citations
Concentration-Dependent Effect of Naringin on Intestinal Absorption of β1-Adrenoceptor Antagonist Talinolol Mediated by P-Glycoprotein and Organic Anion Transporting Polypeptide (Oatp)
2008 • 83 citations
Involvement of MRP4 (ABCC4) in the Luminal Efflux of Ceftizoxime and Cefazolin in the Kidney
2007 • 83 citations
Gene Expression in the Human Intestine and Correlation with Oral Valacyclovir Pharmacokinetic Parameters
2003 • 82 citations
Establishment of a Set of Double Transfectants Coexpressing Organic Anion Transporting Polypeptide 1B3 and Hepatic Efflux Transporters for the Characterization of the Hepatobiliary Transport of Telmisartan Acylglucuronide
2008 • 80 citations
Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung
2002 • 79 citations
Permeability Dominates in Vivo Intestinal Absorption of P-gp Substrate with High Solubility and High Permeability
2005 • 77 citations
Application and limitation of inhibitors in drug–transporter interactions studies
2007 • 75 citations
Drug Transporters: Their Role and Importance in the Selection and Development of New Drugs
2002 • 74 citations
A LC–MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1
2005 • 74 citations
The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique
2003 • 74 citations
Characterization of Substrates and Inhibitors for the In Vitro Assessment of Bcrp Mediated Drug–Drug Interactions
2008 • 73 citations
Topotecan Is a Substrate for Multidrug Resistance Associated Protein 4
2005 • 72 citations
Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol
2008 • 72 citations
Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance
2008 • 70 citations
Interactions of Human- and Rat-Organic Anion Transporters With Pravastatin and Cimetidine
2004 • 68 citations
Involvement of Multidrug Resistance-Associated Protein 2 (Abcc2) in Molecular Weight-Dependent Biliary Excretion of β-Lactam Antibiotics
2008 • 68 citations
Effects of Grapefruit Juice on Intestinal P‐glycoprotein: Evaluation Using Digoxin in Humans
2003 • 65 citations
Hepatic drug transporters and nuclear receptors: Regulation by therapeutic agents
2008 • 60 citations
MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects.
2003 • 60 citations
A Novel Inhibitor of the Mammalian Peptide Transporter PEPT1
2001 • 55 citations
Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells
2003 • 53 citations
Expression, Localisation and Activity of ATP Binding Cassette (ABC) Family of Drug Transporters in Human Amnion Membranes
2007 • 53 citations
Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2
2005 • 51 citations
Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes
2006 • 50 citations
4‐Aminomethylbenzoic acid is a non‐translocated competitive inhibitor of the epithelial peptide transporter PepT1
1998 • 50 citations
The Use of Drug Metabolism for Prediction of Intestinal Permeability
2009 • 49 citations
Altered Oral Bioavailability and Pharmacokinetics of P-Glycoprotein Substrates by Coadministration of Biochanin A
2006 • 47 citations
Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir
2008 • 44 citations
Impact of Basolateral Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 on the Hepatobiliary Disposition of Fexofenadine in Perfused Mouse Livers
2008 • 43 citations
Orange juice increased the bioavailability of pravastatin, 3-hydroxy-3-methylglutaryl CoA reductase inhibitor, in rats and healthy human subjects
2006 • 41 citations
The MDCK cell line is made up of populations of cells with diverse resistive and transport properties
2000 • 41 citations
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV‐infected patients
2007 • 40 citations
Activation of CFTR by ASBT-mediated bile salt absorption
2005 • 37 citations
The Role of Permeability in Drug ADME/PK, Interactions and Toxicity—Presentation of a Permeability-Based Classification System (PCS) for Prediction of ADME/PK in Humans
2007 • 37 citations
Using novobiocin as a specific inhibitor of breast cancer resistant protein to assess the role of transporter in the absorption and disposition of topotecan
2007 • 36 citations
Differential kinetics of transport of 2',3'-dideoxyinosine and adenosine via concentrative Na+ nucleoside transporter CNT2 cloned from rat blood-brain barrier.
2001 • 35 citations
Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients
2003 • 34 citations
Synthesis, Flow Cytometric Evaluation, and Identification of Highly Potent Dipyridamole Analogues as Equilibrative Nucleoside Transporter 1 Inhibitors
2007 • 33 citations
Pharmacogenetics of Intestinal Absorption
2008 • 32 citations
A Possible Role of Multidrug Resistance–Associated Protein 2 (Mrp2) in Hepatic Excretion of PCB126, an Environmental Contaminant: PBPK/PD Modeling
2008 • 26 citations
Glucuronidation Converting Methyl 1-(3,4-Dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) to a Potent Apical Sodium-Dependent Bile Acid Transporter Inhibitor, Resulting in a Hypocholesterolemic Action
2007 • 23 citations
Explorations into modeling human oral bioavailability
2008 • 19 citations
Hypoxanthine uptake and release by equilibrative nucleoside transporter 2 (ENT2) of rat microvascular endothelial cells
2007 • 18 citations
Endogenous expression of liver-specific drug transporters for organic anions in the rat hepatocytoma fusion cell line HPCT-1E3
2005 • 11 citations
Interaction of nucleoside‐derivatives with the human Na + /nucleoside cotransporters CNT1 and CNT3
2008 • 1 citations